Antiaging Dock: Evaluation of Sarcopenia

In 1989, Rosenberg advocated the importance of the decrease in skeletal muscle mass with aging, and proposed the term “sarcopenia,” a compound word from the Greek “sarx (muscle)” and “penia (loss)” [1]. Subsequently, in 2010, the European Working Group on Sarcopenia in Older People (EWGSOP) presented the world’s first consensus on sarcopenia [2]. This includes not only the decrease in muscle mass, which had been traditionally treated, but also the evaluation of muscle strength and physical function. Since then, various research groups such as the Asian Working Group for Sarcopenia (AWGS) have created diagnostic criteria for sarcopenia, and these criteria commonly include the evaluation of muscle mass, muscle strength, and physical function.